News 2016-12-29T17:09:02+00:00

Lipum in EMBL Alumni Report 2017

The European Molecular Biology Laboratory (EMBL) was founded more than 40 years ago to be a centre of excellence for Europe’s most talented young scientists in the life sciences. In the Alumni Impact Report 2017 companies co-founded by [...]

January 15th, 2018|Tags: , , |

Horizon 2020 – Seal of Excellence

Seal of Excellence Certificate by European Commission In response to Lipums application ”Novel Target for Treatment of Chronic Inflammatory Diseases” for SME Instrument 2 funding by EU’s Horizon 2020 an international panel of independent experts scored [...]

November 30th, 2017|

November, meet us in Berlin and New York

Learn more about our novel target for treatment of chronic inflammatory diseases. We will attend: BIO-Europe in Berlin, Nov 6-8 Nordic-American conference in New York, Nov 13-14 RESI meeting in New York, Nov 15 We [...]

November 2nd, 2017|

BIO-Europe in Berlin Nov 6-8, meet Lipum there.

Lipum offer a new route for treatment of chronic inflammatory diseases. Meet with our CEO Einar Pontén at BIO-Europe 2017 in Berlin, Nov 6-8. We will tell you more on our novel target Bile Salt-Stimulated Lipase [...]

November 2nd, 2017|

17th Annual Biotech in Europe Forum

We invite investors to join us in the development towards better treatment of chronic inflammations. Meet us and learn more at the 17th Annual Biotech in Europe Forum, Basel, Sept 26-27.

September 25th, 2017|

Meet Lipum at NLSDays in Malmö, Sept 12-14

Lipum offer a new route for treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Contact us and meet with our CEO Einar Pontén at Nordic Life Science Days 2017 [...]

August 18th, 2017|